natural glp-1 receptor agonist Potential Use of and GIP/GLP-1 Agonists for Respiratory Disorders: Where Are We at? Comparison of short-acting versus long-acting
Description
In 1993 Holst and his colleagues had noted GLP-1 receptors in the vagal nerve which runs from the gut to the brain
The main differences across comparison categories are: Mechanism of Action: advantage goes to neither (tie)
More recently, attention has shifted from the gut to these drugs effects in the brainspecifically, systems that regulate motivation, reward, and behavior
Reference: Paggers L, Mesotten D, Stragier H
2013;98:E664E671
This question has emerged as consumers seek natural alternatives to prescription medications for blood sugar management
